Researchers investigated the potential association between cutaneous lymphoma and anti-TNFα therapy in a recent study.

News

News
Monday, December 21, 2015
Apremilast, an oral phosphodiesterase-4 inhibitor, can reduce the severity of nail and scalp psoriasis. 
News
Friday, May 8, 2015
Off label use of biologics for an increasing array of skin diseases is becoming more common as researchers learn more about these drugs, particularly newer generation biologics.